A 3-week schedule of gemcitabine plus cisplatin as induction chemotherapy for Stage III non-small cell lung cancer.

M Rita Migliorino,Filippo De Marinis,Fabrizio Nelli, Franco Facciolo, M Vittoria Ammaturo,Antonio Cipri,Raffaele Belli,Ottavio Ariganello,Francesco Diana,Michele Di Molfetta,Olga Martelli

Lung cancer (Amsterdam, Netherlands)（2002）

Cited 30|Views14

No score

Abstract

The 3-week schedule of gemcitabine plus cisplatin is highly active as induction chemotherapy in Stage IIIA N(2) unresectable NSCLC. This suggests a need for a multimodality approach upfront, such as concurrent chemoradiation therapy, particularly in patients with Stage IIIB disease.

Translated text

Key words

gemcitabine,cisplatin,induction chemotherapy,non-small cell lung cancer (NSCLC)

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined